A team of doctors and researchers is looking to adapt a test kit for heart failure to help doctors single out which dengue patients are at risk of severe dengue during the early stages of the disease.

The kits, which are commercially available, can be modified to take advantage of a recent finding by a team from Nanyang Technological University (NTU) and the National Centre for Infectious Diseases (NCID), who identified two compounds in the blood of dengue patients that could determine if a patient is at risk of severe dengue.